| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | — | -39.2% |
| R&D Expense | $17.6M | — | -33.8% |
| SG&A Expense | $10.2M | — | -23.5% |
| Operating Income | -$25.0M | — | +67.2% |
| Interest Expense | $1.1M | — | -51.6% |
| Net Income | -$25.0M | — | +67.2% |
| EPS (Basic) | -$0.26 | — | +71.7% |
| EPS (Diluted) | -$0.26 | — | +71.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $123.6M | -15.7% | -10.8% |
| Accounts Receivable | $2.6M | -82.9% | +408.2% |
| Current Assets | $128.1M | -21.9% | -43.0% |
| Total Assets | $149.3M | -19.9% | -43.4% |
| Current Liabilities | $39.8M | -14.0% | -45.6% |
| Long-term Debt | $47.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.1M | — | +51.8% |
| Capital Expenditures | $92K | — | -19.3% |
| Investing Cash Flow | $64K | — | -99.9% |
| Financing Cash Flow | $0 | — | +100.0% |
| Free Cash Flow | -$23.2M | — | +51.7% |
| -4.8% |
| Total Liabilities | $144.9M | -9.0% | -28.0% |
| Stockholders' Equity | $4.4M | -83.8% | -92.9% |